Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Literature
1.
Aslani P, Benrimoj S, Krass I. Use of CMI by NSW community pharmacists—a baseline study. Aust Pharm. 1998;17:15–20.
2.
Koo M, Krass I, Aslani P. Patient characteristics influencing evaluation of written medicine information: lessons for patient education. Ann Pharmacother. 2005;39:1434–40.CrossRefPubMed
3.
Koo M, Krass I, Aslani P. Consumer use of consumer medicine information. J Pharm Pract Res. 2005;35(2):94–8.
4.
Koo M, Krass I, Aslani P. Enhancing patient education about medicines: factors influencing reading and seeking of written medicine information. Health Expect. 2006;9:174–87.CrossRefPubMed
5.
Raynor D, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharm J. 2000;264:268–70.
Metadata
Title
Written medicine information in Australia
Author
Parisa Aslani
Publication date
01-12-2009
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9329-5

Other articles of this Issue 6/2009

International Journal of Clinical Pharmacy 6/2009 Go to the issue

Research Article

Medication review and patient counselling at discharge from the hospital by community pharmacists

Short Research Report

Electronic reminders to improve medication adherence—are they acceptable to the patient?

Research Article

Continuing education needs assessment of pharmacists in the United Arab Emirates

Short Research Report

Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service

Research Article

Prescribing errors during hospital inpatient care: factors influencing identification by pharmacists

Review Article

The changing roles of pharmacists in community pharmacies: perception of reality in India

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits